Three Perth pharmaceutical companies will take a share of a $12 million funding injection by the federal government to develop Australian-made heart disease and diabetes treatments.
Today's board moves wrap includes Liqun Li, Ryan Parkin, Adrian Byass, Colin McIntyre, Aaron Brinkworth, Roger Moore, James Williams, Neville Gardiner, Cullum Winn and Warren Thorne.
Today's board moves wrap includes KC Ong, Mark Etherton, Rob Black, Maree Arnason, Greg Evans, James Williams, Angus Barker, Annie Liu, Gavin Rezos and more.
Two Western Australia health projects are among 19 national recipients sharing $12 million in commercial acceleration funding from a CSIRO-backed fund.
Peter Meurs and Perth-based Merchant Group have invested $9.5 million in biopharmaceutical company Dimerix, as part of a broader capital raising to fast-track clinical studies.
Our weekly appointments wrap includes Jessica Machin, Clint Bracknell, Mimi Packer, James Williams, Peter Cook, Marianne Dravnieks, Andrew Kennedy, Fiona Murfitt and Giulia Savior.
Nicholas Clark has retired as executive director, strategy at Alexium International Group to focus on his young family in the US following the unexpected loss of his wife last year.
Local biotech firm Sun Biomedical has announced plans to buy Melbourne-based Dimerix Bioscience in exchange for a share package worth about $8.3 million.
FEATURE: The state's biotechnology sector is heating up as investors look for the next wave of investment opportunities amid waning resources investment.
